| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.4 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.5 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |